³Ô¹ÏÍøÕ¾

Latest

Latest biotechnology News | Page 11

  • Latest biotechnology news stories and updates. What is happening today? All recent biotechnology news and developments. Live coverage and timeline of biotechnology. All you need to know about biotechnology.
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
Anteris reports positive results from interim analysis of its US-EFS Trial for DurAVR THV
Imugene announces phase 1 clinical trial opens with onCARlytics CD19 virus technology
Top performing ASX life science companies 26 October
HKUST President Prof. Nancy IP Welcomes Policy Address
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
AdAlta reports favourable patient tolerability after third dose in AD-214 extension study
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
AusBioInvest 2023 programme launched
Strength in diversity – computing healthy microbiome relationships
Shortage in regional nuclear medicine workforce attracts new financial support
J.P. Morgan’s chairman of investment banking announced as AusBioInvest keynote
New view of gene therapy
Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
Victoria backing Australia’s first stem cell trial for rare genetic disorder
Plasma jet tech transforms microalgae
Australian biotechnologists and scientists celebrated in Prime Minister’s Prizes for Science
With Proton Pump to More Growth
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
Oculus BioMed partners with The Centre for Eye Research Australia in a deal to develop ‘SwitchGene’
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Posthumous recognition of benevolent billionaire
FivepHusion announces the appointment of experienced industry executive to its board
Training session on new Prescribed List products
CSL announces seven new Global Research Acceleration Initiative projects
Dimerix and Advanz Pharma enter agreement to commercialise DMX-200 in major markets
US FDA grants Orphan Drug Designation for Noxopharm’s CRO-67
Director appointed to Australia’s Cell and Gene Catalyst
Amended Notice of AusBiotech’s AGM 2023
A name change and significant sale as Pharmaxis becomes Syntara
Increase your company profile via global life sciences Directory
The University of Manchester secures major bioscience funding to harness the activity of microbiomes for a more sustainable future
Next stop: retina
³Ô¹ÏÍøÕ¾ team to advance innovative biopolymer particle-based platform technology
Starpharma announces the presentation of DEP irinotecan combination data
Novel therapeutics development highlighted in Australasian Biotechnology journal
PolyNovo updates investors with significant revenue growth
US FDA grants conditional approval to the brand name of Dimerix’s DMX-200
HealthTech InnovationAus award finalists announced
BioCurate and Takeda renew alliance to accelerate discoveries
AusBiotech announces CEO departure
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Moderna marks half-way point in construction of mRNA manufacturing facility
Optiscan Imaging correlates with histology in breast cancer study
Australian-developed drug receives US FDA approval
University of Canterbury researchers win large-scale funding to solve real-world challenges
Global recognition for biomedical innovator
Adapt Ideations announces the appointment of chief operating officer

© 2025 - ³Ô¹ÏÍøÕ¾